{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T10:19:47Z","timestamp":1783073987572,"version":"3.54.6"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,8,1]]},"DOI":"10.2146\/ajhp110308","type":"journal-article","created":{"date-parts":[[2012,7,19]],"date-time":"2012-07-19T20:58:44Z","timestamp":1342731524000},"page":"1295-1302","source":"Crossref","is-referenced-by-count":11,"title":["Stem cell transplantation for treatment of sickle cell disease: Bone marrow versus cord blood transplants"],"prefix":"10.1093","volume":"69","author":[{"given":"Lisa Marie","family":"Thompson","sequence":"first","affiliation":[{"name":"Banner, MD, Anderson Cancer Center, Gilbert, AZ."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Estela","family":"Ceja","sequence":"additional","affiliation":[{"name":"University of Texas MD Anderson Cancer Center, Houston."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonal Patel","family":"Yang","sequence":"additional","affiliation":[{"name":"Norman Regional Health System, Norman, OK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"2019041607090279600_b1-0691295","unstructured":"Centers for Disease Control and Prevention. Sickle cell disease. www.cdc.gov\/ncbddd\/sicklecell\/index.html (accessed 2011 May 1)."},{"key":"2019041607090279600_b2-0691295","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.pcl.2010.01.003","article-title":"Hematopoietic stem cell transplantation for hemoglobinopathies: current practice and emerging trends","volume":"57","author":"Smiers","year":"2010","journal-title":"Pediatr Clin North Am."},{"key":"2019041607090279600_b3-0691295","unstructured":"National Heart, Lung, and Blood Institute. What is sickle cell anemia?www.nhlbi.nih.gov\/health\/dci\/Diseases\/Sca\/SCA_WhatIs.html (accessed 2011 May 1)."},{"key":"2019041607090279600_b4-0691295","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1056\/NEJM198409203111207","article-title":"Bone marrow transplantation in a patient with sickle cell anemia","volume":"311","author":"Johnson","year":"1984","journal-title":"N Engl J Med."},{"key":"2019041607090279600_b5-0691295","first-page":"100","article-title":"Barriers to bone marrow transplant for sickle cell anemia","volume":"2","author":"Walters","year":"1996","journal-title":"Biol Blood Marrow Transplant."},{"key":"2019041607090279600_b6-0691295","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1053\/bbmt.2002.v8.pm11858190","article-title":"Morbidity and mortality of chronic GVHD after hematopoietic stem cell transplant from HLA-identical siblings for patients with aplastic or refractory anemias","volume":"8","author":"Goerner","year":"2002","journal-title":"Biol Blood Marrow Transplant."},{"key":"2019041607090279600_b7-0691295","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1056\/NEJMct0708272","article-title":"Hydroxyurea for the treatment of sickle cell anemia","volume":"358","author":"Platt","year":"2008","journal-title":"N Engl J Med."},{"key":"2019041607090279600_b8-0691295","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/S0140-6736(10)61029-X","article-title":"Sickle-cell disease","volume":"376","author":"Rees","year":"2010","journal-title":"Lancet."},{"key":"2019041607090279600_b9-0691295","volume-title":"Hydrea (hydroxyurea) package insert","year":"2001"},{"key":"2019041607090279600_b10-0691295","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1016\/j.ijid.2009.03.010","article-title":"Infection in sickle cell disease: a review","volume":"14","author":"Booth","year":"2010","journal-title":"Int J Infect Dis."},{"key":"2019041607090279600_b11-0691295","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1136\/adc.2007.116699","article-title":"Standards for the management of sickle cell disease in children","volume":"93","author":"Dick","year":"2008","journal-title":"Arch Dis Child Educ Pract Ed."},{"key":"2019041607090279600_b12-0691295","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/MPH.0b013e3181b83cab","article-title":"Decision analysis of treatment strategies in children with severe sickle cell disease","volume":"31","author":"O\u2019Brien","year":"2009","journal-title":"J Pediatr Hematol Oncol."},{"key":"2019041607090279600_b13-0691295","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1517\/14712598.7.2.161","article-title":"Hematopoietic cell transplantation for sickle cell disease: state of the art","volume":"7","author":"Krishnamurti","year":"2007","journal-title":"Expert Opin Biol Ther."},{"key":"2019041607090279600_b14-0691295","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1056\/NEJM200001133420203","article-title":"Prediction of adverse outcomes in children with sickle cell disease","volume":"342","author":"Miller","year":"2000","journal-title":"N Engl J Med."},{"key":"2019041607090279600_b15-0691295","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1056\/NEJM199608083350601","article-title":"Bone marrow transplantation for sickle cell disease","volume":"335","author":"Walters","year":"1996","journal-title":"N Engl J Med."},{"key":"2019041607090279600_b16-0691295","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1517\/14712598.3.8.1215","article-title":"Haematopoietic cell transplantation in the treatment of sickle cell disease","volume":"3","author":"Atkins","year":"2003","journal-title":"Expert Opin Biol Ther."},{"key":"2019041607090279600_b17-0691295","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMra052638","article-title":"Hematopoietic stem-cell transplantation","volume":"354","author":"Copelan","year":"2006","journal-title":"N Engl J Med."},{"key":"2019041607090279600_b18-0691295","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/sj.bmt.1705943","article-title":"Hematopoietic cell transplantation for thalassemia and sickle cell disease: past, present and future","volume":"41","author":"Bhatia","year":"2008","journal-title":"Bone Marrow Transplant."},{"key":"2019041607090279600_b19-0691295","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/pbc.20169","article-title":"Bone marrow transplantation for sickle cell anemia: progress and prospects","volume":"44","author":"Iannone","year":"2005","journal-title":"Pediatr Blood Cancer."},{"key":"2019041607090279600_b20-0691295","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.pcl.2010.01.004","article-title":"Stem cell source and outcome after hematopoietic stem cell transplantation (HSCT) in children and adolescents with leukemia","volume":"57","author":"Peters","year":"2010","journal-title":"Pediatr Clin North Am."},{"key":"2019041607090279600_b21-0691295","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1097\/01.TP.0000174340.40585.D4","article-title":"Effects of immunosuppressive agents on magnesium metabolism early after allogenic hematopoietic stem cell transplantation","volume":"80","author":"Asia","year":"2005","journal-title":"Transplantation."},{"key":"2019041607090279600_b22-0691295","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.bbmt.2005.09.012","article-title":"Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Bone Marrow Transplantation, the Center for International Blood and Marrow Transplantation Research, and the American Society of Blood and Marrow Transplantation","volume":"12","author":"Rizzo","year":"2006","journal-title":"Biol Blood Marrow Transplant."},{"key":"2019041607090279600_b23-0691295","first-page":"1918","article-title":"Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report. Multicenter investigation of bone marrow transplantation for sickle cell disease","volume":"95","author":"Walters","year":"2000","journal-title":"Blood."},{"key":"2019041607090279600_b24-0691295","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1182\/blood.V85.4.879.bloodjournal854879","article-title":"Neurologic complications after allogeneic marrow transplantation for sickle cell anemia","volume":"85","author":"Walters","year":"1995","journal-title":"Blood."},{"key":"2019041607090279600_b25-0691295","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.bbmt.2008.03.001","article-title":"Granulocyte colony-stimulating factor-based stem cell mobilization in patients with sickle cell disease","volume":"14","author":"Rosenbaum","year":"2008","journal-title":"Biol Blood Marrow Transplant."},{"key":"2019041607090279600_b26-0691295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.bmt.1701291","article-title":"Haematopoietic stem cell transplantation for sickle cell anaemia: the first 50 patients transplanted in Belgium","volume":"22","author":"Vermylen","year":"1998","journal-title":"Bone Marrow Transplant."},{"key":"2019041607090279600_b27-0691295","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2141.2007.06592.x","article-title":"Matched-related donor transplantation for sickle cell disease: report from the Center for International Blood and Marrow Transplant Research","volume":"137","author":"Panepinto","year":"2007","journal-title":"Br J Haematol."},{"key":"2019041607090279600_b28-0691295","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1083-8791(03)00192-7","article-title":"Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and \u03b2-thalassemia","volume":"9","author":"Iannone","year":"2003","journal-title":"Biol Blood Marrow Transplant."},{"key":"2019041607090279600_b29-0691295","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1182\/blood-2007-03-079665","article-title":"Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease","volume":"110","author":"Bernaudin","year":"2007","journal-title":"Blood."},{"key":"2019041607090279600_b30-0691295","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/CCO.0b013e328324ba04","article-title":"Blood and marrow transplantation for sickle cell disease: overcoming barriers to success","volume":"21","author":"Bolanos-Meade","year":"2009","journal-title":"Curr Opin Oncol."},{"key":"2019041607090279600_b31-0691295","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/00043426-200009000-00010","article-title":"Successful cord blood transplantation for sickle cell anemia from a sibling who is human leukocyte antigen-identical: implications for comprehensive care","volume":"22","author":"Gore","year":"2000","journal-title":"J Pediatr Hematol Oncol."},{"key":"2019041607090279600_b32-0691295","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1056\/NEJM198910263211707","article-title":"Hematopoietic reconstitution in a patient with Fanconi\u2019s anemia by means of umbilical-cord blood from an HLA-identical sibling","volume":"321","author":"Gluckman","year":"1989","journal-title":"N Engl J Med."},{"key":"2019041607090279600_b33-0691295","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/bmt.2009.286","article-title":"Future of cord blood for oncology uses","volume":"44","author":"Brunstein","year":"2009","journal-title":"Bone Marrow Transplant."},{"key":"2019041607090279600_b34-0691295","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1182\/blood-2002-07-2090","article-title":"Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease","volume":"101","author":"Locatelli","year":"2003","journal-title":"Blood."},{"key":"2019041607090279600_b35-0691295","first-page":"3662","article-title":"Factors associated with outcome after cord blood transplantation in children with acute leukemia","volume":"93","author":"Locatelli","year":"1999","journal-title":"Blood."},{"key":"2019041607090279600_b36-0691295","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1399-3046.2007.00725.x","article-title":"Unrelated cord blood transplantation in children with sickle cell disease: review of four-center experience","volume":"11","author":"Adamkiewicz","year":"2007","journal-title":"Pediatr Transplant."},{"key":"2019041607090279600_b37-0691295","first-page":"29","article-title":"Identification of unrelated cord blood units for hematopoietic stem cell transplantation in children with sickle cell disease","volume":"28","author":"Adamkiewicz","year":"2006","journal-title":"J Pediatr Hematol Oncol."}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/69\/15\/1295\/28455049\/ajhp1295.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,11]],"date-time":"2020-07-11T05:50:59Z","timestamp":1594446659000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/69\/15\/1295\/5111926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,1]]},"references-count":37,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2012,8,1]]}},"URL":"https:\/\/doi.org\/10.2146\/ajhp110308","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2012,8,1]]},"published":{"date-parts":[[2012,8,1]]}}}